Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q1

6523.TEDINET S100RO21
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥81.3bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥356.4bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥81.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥1.7bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥2.0bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax−¥3.6bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥179m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥3.2bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥3.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥7.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥3.1bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income−¥7.0bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥572.5bnat 2023-06-30Cons.Assets IFRS
Total assets¥561.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥595.7bnat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥428.9bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥422.7bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥143.7bnat 2023-06-30Cons.Equity IFRS
Net assets / equity¥138.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥137.7bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥144.0bnat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥138.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥136.9bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥54.1bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥82.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥8.2bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥21.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥14.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥11.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-25.52023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-25.842022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-57.262022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-25.52023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-25.842022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-57.262022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio25.2%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.6%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio23.0%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥2.2bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
—segment totalrevenue2023-04-01 → 2023-06-30¥80.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥80.8bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.9bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥6.7bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.0bn
—segment totalrevenue2022-04-01 → 2022-06-30¥80.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥80.9bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥8.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 864
ItemContextValueUnit
Liabilities and equity IFRSCurrentQuarterInstant572547000000JPY
Revenue IFRSPrior1YTDDuration81502000000JPY
Revenue IFRSCurrentYTDDuration81325000000JPY
Cost of sales IFRSPrior1YTDDuration43364000000JPY
Cost of sales IFRSCurrentYTDDuration43929000000JPY
Gross profit IFRSPrior1YTDDuration38138000000JPY
Gross profit IFRSCurrentYTDDuration37396000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration36596000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration35625000000JPY
Other income IFRSPrior1YTDDuration1119000000JPY
Other income IFRSCurrentYTDDuration128000000JPY
Other expenses IFRSPrior1YTDDuration488000000JPY
Other expenses IFRSCurrentYTDDuration101000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-125000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-85000000JPY
Operating profit loss IFRSPrior1YTDDuration2046000000JPY
Operating profit loss IFRSCurrentYTDDuration1712000000JPY
Finance income IFRSPrior1YTDDuration77000000JPY
Finance income IFRSCurrentYTDDuration343000000JPY
Finance costs IFRSPrior1YTDDuration8421000000JPY
Finance costs IFRSCurrentYTDDuration5644000000JPY
Profit loss before tax IFRSPrior1YTDDuration-6297000000JPY
Profit loss before tax IFRSCurrentYTDDuration-3588000000JPY
Income tax expense IFRSPrior1YTDDuration741000000JPY
Income tax expense IFRSCurrentYTDDuration-438000000JPY
Profit loss IFRSPrior1YTDDuration-7038000000JPY
Profit loss IFRSCurrentYTDDuration-3149000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration-7106000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration-3200000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration67000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration50000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration-57.26
Basic earnings loss per share IFRSCurrentYTDDuration-25.50
Diluted earnings loss per share IFRSPrior1YTDDuration-57.26
Diluted earnings loss per share IFRSCurrentYTDDuration-25.50
Profit loss IFRSPrior1YTDDuration-7038000000JPY
Profit loss IFRSCurrentYTDDuration-3149000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration1182000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration91000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration55000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration981000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration90000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-17000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration11492000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration13998000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration307000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration127000000JPY
Other comprehensive income IFRSPrior1YTDDuration13128000000JPY
Other comprehensive income IFRSCurrentYTDDuration15181000000JPY
Comprehensive income IFRSPrior1YTDDuration6089000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass